Ezetimibe is a nonstatin low-density lipoprotein cholesterol-lowering small molecule drug. Ezetimibe is the only currently FDA-approved approved member of the of intestinal cholesterol reuptake ...
% differences compared with placebo or indicated statin are based on differences of individual least square means for LDL-C, HDL-C, non-HDL-C and apoB, and on differences of individual medians or ...
Although statins are powerful lipid-lowering drugs, many patients with hypercholesterolemia do not reach current treatment goals with statin treatment. Ezetimibe the first approved direct ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback